With its FDA-approved neurostimulator implant aimed at helping patients recover from stroke, MicroTransponder has raised $65 ...

Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...

The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.

MicroTransponder has received $65m in a Series F financing round, which aims to enhance its stroke care offerings with the ...

In Alaska, where access to specialist care is challenging and emergency transfers can be harrowing, providers are using AI to ...

Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

The ambulance would be the latest addition to Florida’s first mobile stroke treatment unit network, which speeds care to ...

A report has warned that stroke victims are facing a postcode lottery to access lifesaving treatment. The Stroke Association ...

Stroke can come out of the blue, even in people who have been healthy all their lives. Unlike some other health conditions that develop gradually, a stroke occurs suddenly when blood flow to the brain ...